🟢 Cue Biopharma is trading 5.9% up today as catalyst remains unclear

Cue Biopharma is trading 5.9% up at $33.49, with no new company-specific announcement identified for September 16, 2026 and the catalyst unclear.

• Latest substantive developments remain the $50 million July private placement and expectations for CUE-221 Phase 2 CSU data by the end of the third quarter.
• The gain is occurring despite biotech weakness; broader Nasdaq strength may provide limited support, but confidence is low.